MarkZafereoMD Profile Banner
Mark Zafereo, MD Profile
Mark Zafereo, MD

@MarkZafereoMD

Followers
679
Following
26
Statuses
17

#ThyroidCancer Surgeon at @MDAndersonNews specializing in papillary, follicular, medullary, and anaplastic #thyroidcancer. Tweets are my own.

Houston, TX
Joined June 2017
Don't wanna be here? Send us removal request.
@MarkZafereoMD
Mark Zafereo, MD
4 years
Congratulations to Dr. Jennifer Wang and the MultiDisciplinary team @MDAndersonNews and @TheMarkFdn for working together to Make Anaplastic Thyroid Cancer History!
@TheMarkFdn
The Mark Foundation for Cancer Research
5 years
Third project is led by @JenniferWangMD, who is seeking to understand the underlying mechanisms for anaplastic thyroid carcinoma tumor resistance to treatment with a combination of dabrafenib and trametinib. More here:
Tweet media one
0
3
19
@MarkZafereoMD
Mark Zafereo, MD
4 years
Neoadjuvant selpercatinib for advanced medullary thyroid cancer Novel treatment strategy for patients with advanced medullary #thyroidcancer @MDAndersonNews @ThyCaInc @EThyroidCancer @britishthyroid @ThyroidNZ
0
6
17
@MarkZafereoMD
Mark Zafereo, MD
4 years
2
3
12
@MarkZafereoMD
Mark Zafereo, MD
4 years
Excited to Demonstrate Transformative Improvement in Overall Survival in Patients With Anaplastic #ThyroidCancer @MDAndersonNews, 2000-2019 @ThyroidFed @ThyCaInc @thyroidfriends @ThyroidChange @EThyroidCancer @britishthyroid @ThyroidNZ
1
7
26
@MarkZafereoMD
Mark Zafereo, MD
5 years
Renewed hope for patients with BRAF-mutated anaplastic thyroid cancer!
@JenniferWangMD
Jennifer R Wang, MD PhD
5 years
Excited to share our experience with surgical resection after targeted therapy with Dabrafenib and Trametinib in BRAF-mutated anaplastic thyroid cancer @MarkZafereoMD @DrMCabanillas @DaduRamona @naifa_busaidy @DrNeilGross @MDAndersonNews @AmThyroidAssn
Tweet media one
0
3
11
@MarkZafereoMD
Mark Zafereo, MD
6 years
Anaplastic Thyroid Cancer Trials at MD Anderson Cancer Center: New Frontiers and Hope @ThyroidFed @ThyCaInc @thyroidfriends @ThyroidChange @EThyroidCancer @britishthyroid @ThyroidNZ
@MDAndersonNews
MD Anderson Cancer Center
6 years
When Max Nickless was diagnosed with anaplastic #thyroidcancer in January 2017, he was given just a few weeks to live. Read how the treatment he found with our @DrMCabanillas and @MarkZafereoMD has given him more time: #thycsm #endcancer
1
7
26
@MarkZafereoMD
Mark Zafereo, MD
6 years
Parapharyngeal Dissection for Papillary Thyroid Cancer | VideoEndocrinology @ThyCaInc @ThyroidChange @EThyroidCancer @thyroidfriends
1
3
12
@MarkZafereoMD
Mark Zafereo, MD
6 years
New hope for patients with Anaplastic #ThyroidCancer Neoadjuvant therapy followed by surgical resection for BRAF-mutated Anaplastic #ThyroidCancer at #ATAthyroid2018 @AmThyroidAssn @MDAndersonNews @PhysRelations @ThyCaInc @EThyroidCancer @thyroidfriends @ThyroidChange
Tweet media one
1
11
61
@MarkZafereoMD
Mark Zafereo, MD
7 years
Microscopic extrathyroidal extension does not predict survival or recurrence in #ThyroidCancer. Time to remove microscopic extrathyroidal extension as a consideration for RAI? @thyroidfriends @ThyroidChange
0
2
6
@MarkZafereoMD
Mark Zafereo, MD
7 years
Microscopic extrathyroidal extension does not predict survival or recurrence in #ThyroidCancer. Time to remove microscopic extrathyroidal extension as a consideration for RAI? @MDAndersonNews @PhysRelations @ThyCaInc @EThyroidCancer @AmThyroidAssn
0
7
11
@MarkZafereoMD
Mark Zafereo, MD
7 years
Gross strap muscle invasion may not be important survival prognostic factor for staging purposes in #ThyroidCancer. To be considered for next AJCC staging. @MDAndersonNews @PhysRelations @ThyCaInc @thyroidfriends @ThyroidChange @EThyroidCancer
0
5
9
@MarkZafereoMD
Mark Zafereo, MD
7 years
Otolaryngology United for Global Patient Care: Join the AAO-HNSF Humanitarian Effort by Donating Medical Supplies and Instruments Today! #globalENTcare #donateENTsupplies #OTOMTG18 @AAOHNS
Tweet media one
0
0
3
@MarkZafereoMD
Mark Zafereo, MD
7 years
Making Anaplastic Thyroid Cancer History @thyroidfriends @ThyroidChange Neoadjuvant BRAF- and immune- directed therapy for anaplastic thyroid carcinoma | Thyroid
0
0
1
@MarkZafereoMD
Mark Zafereo, MD
7 years
Making Anaplastic Thyroid Cancer History @MDAndersonNews @PhysRelations @ThyCaInc @AmThyroidAssn Neoadjuvant BRAF- and immune- directed therapy for anaplastic thyroid carcinoma | Thyroid
0
6
15
@MarkZafereoMD
Mark Zafereo, MD
7 years
Honored to host Dr. Bob Ferris as the 15th Helmuth Goepfert Distinguished Visiting Professor at @MDAndersonNews Bob is now an honorary Texan! @UPMCnews
Tweet media one
Tweet media two
Tweet media three
0
1
16
@MarkZafereoMD
Mark Zafereo, MD
7 years
New #ThyroidCancer study from @MDAndersonNews Association of Lymph Node Density With Survival in Papillary Thyroid Cancer @AmThyroidAssn @thyroidfriends @ThyroidChange @ThyCaInc
1
5
12
@MarkZafereoMD
Mark Zafereo, MD
7 years
1
0
2